Sonoma Pharmaceuticals | 8-K: Current report
Apr 9 07:34 ET
Sonoma Pharmaceuticals | 8-K: Current report
Apr 2 07:34 ET
Sonoma Pharmaceuticals | 8-K: Current report
Mar 22 16:34 ET
Sonoma Pharmaceuticals | 424B3: Prospectus
Mar 8 16:34 ET
Sonoma Pharmaceuticals | 8-K: Current report
Mar 8 16:31 ET
Sonoma Pharmaceuticals | 10-Q: Quarterly report
Feb 8 16:08 ET
Sonoma Pharmaceuticals | 8-K: Current report
Jan 10 00:00 ET
Sonoma Pharmaceuticals | 8-K: Current report
Jan 9 00:00 ET
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Trombly Amy Moss
Dec 29, 2023 00:00 ET
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Dal Poggetto John
Dec 29, 2023 00:00 ET
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Thornton Bruce
Dec 29, 2023 00:00 ET
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer DVONCH JEROME J
Dec 29, 2023 00:00 ET
Sonoma Pharmaceuticals | 8-K: Current report
Dec 29, 2023 00:00 ET
Sonoma Pharmaceuticals | 8-K: Current report
Dec 15, 2023 18:14 ET
Sonoma Pharmaceuticals | 424B3: Prospectus
Dec 15, 2023 17:30 ET
Sonoma Pharmaceuticals | 424B5: Prospectus
Nov 22, 2023 16:30 ET
Sonoma Pharmaceuticals | EFFECT: Others
Nov 21, 2023 00:15 ET
Sonoma Pharmaceuticals | CORRESP: CORRESP
Nov 17, 2023 07:30 ET
Sonoma Pharmaceuticals: Q2 2024 Earnings Report
Nov 13, 2023 16:01 ET
Sonoma Pharmaceuticals | UPLOAD: Others
Nov 7, 2023 11:36 ET
No Data
No Data